Plain-English translation of NCT07323927 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing whether a medication called can help people with mild to moderate Alzheimer's disease. You would receive the medication as injections under your skin over a six-month period. Researchers will carefully monitor how well the treatment works and whether it is safe.
Alzheimer's disease causes progressive memory loss and thinking problems, and doctors are looking for new treatments that might slow down or help manage these symptoms. This medication targets proteins in the brain that are thought to contribute to Alzheimer's, so researchers want to see if it can make a real difference for patients.
You likely qualify if…
You likely don't qualify if…
You would visit the research center regularly over about 9 months total. You would receive an initial injection of the medication, then smaller injections every four weeks for six months. You would also have brain imaging scans and cognitive tests at certain visits to help doctors understand how the treatment is working. A caregiver would need to accompany you to visits and be involved in your care throughout the study.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China